It is focused on delivering meaningful products to improve patients' lives while focusing on creating shareholder value by acquiring, developing and commercializing products primarily in cardiovascular, pain and other specialty areas.

The company's global headquarters are in Ontario, Canada, the US headquarters are planned to be in Princeton, New Jersey, and the Irish headquarters are in Dublin.